Trident Texofab Limited has submitted to exchange statement of deviation and vartiation for the quarter ended on 31.12.2024
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31.12.2024
View original source (BSE India)Trident Texofab Ltd. on 6ix
In the deck
Story so far
Earlier from Trident Texofab
- Result-Financial Result For The Quarter And Nine Months Ended On 31.12.2024
- Board Meeting Outcome for Outcome Of Board Meeting Held On 03.02.2025
- Trident Texofab Ltd. Press Release Jan 29 2025
- Board Meeting Intimation for Consider And Approve Of Un-Audited Financial Result For The Quarter And Nine Month Ended On 31.12.2024
- Trident Texofab Ltd. Press Release Dec 30 2024
Later from Trident Texofab
- Integrated Filing (Financial)
- Trident Texofab Ltd. Press Release Feb 03 2025
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Trident Texofab Ltd. Press Release Feb 05 2025
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab